Scarica l'app Stockscreener
782.17
0.65%
-5.14
Dopo l'orario di chiusura:
790.20
8.03
+1.03%
Argen X Se Adr Borsa (ARGX) Ultime notizie
RBC Capital maintains argenx stock price target at $890 on uptake potential - Investing.com
Earnings call transcript: Argenx beats EPS forecast in Q1 2026 By Investing.com - Investing.com Australia
Earnings call transcript: Argenx beats EPS forecast in Q1 2026 - Investing.com
Argenx beats profit forecasts despite revenue miss By Investing.com - Investing.com South Africa
argenx posts 63% revenue growth on strong Vyvgart sales By Investing.com - Investing.com South Africa
argenx appoints Karen Massey as CEO, founder moves to chair - Investing.com
argenx to Present at BofA Securities 2026 Health Care Conference - ChartMill
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer - ChartMill
ARGX.BR Technical Analysis | Trend, Signals & Chart Patterns | ARGENX SE (EBR:ARGX) - ChartMill
argenx to Report First Quarter 2026 Financial Results and Business Update on May 7, 2026 - ChartMill
ARGX Stock Price, Quote & Chart | ARGENX SEADR (NASDAQ:ARGX) - ChartMill
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Regeneron (REGN) - The Globe and Mail
argenx SE Stock Baskets | MEX:ARGXN - GuruFocus
argenx SE Stock Operating Data - GuruFocus
argenx SE (MEX:ARGXN) Stock News, Headlines & Updates - GuruFocus
US-Listed European ADRs Slipped As Drugmakers Weighed On The Tape - Finimize
Argenx SE stock (NL0010832176): Is its rare disease focus strong enough to unlock sustained U.S. gro - AD HOC NEWS
Argenx SE stock (NL0010832176): Is Vyvgart's momentum strong enough to unlock new upside? - AD HOC NEWS
Argenx SE stock (NL0010832176): Is Vyvgart's expansion strong enough to unlock new upside? - AD HOC NEWS
Argenx SE stock (NL0010832176): Is Vyvgart's rare disease dominance strong enough to unlock new upsi - AD HOC NEWS
Argenx SE stock (NL0010832176): Is Vyvgart's U.S. momentum strong enough to unlock new upside? - AD HOC NEWS
argenx SE (MEX:ARGXN) Competitors 2026 - GuruFocus
Who's Buying or Selling argenx SE (MEX:ARGXN) Stock Today? - GuruFocus
argenx SE (MEX:ARGXN) Stock Price, Trades & News - GuruFocus
argenx SE (MEX:ARGXN)Valuation Measures & Financial Statistics - GuruFocus
argenx Brings Neuromuscular Leadership to AAN 2026 with New Data Supporting Broader VYVGART Use Across MG and CIDP - ChartMill
Analysts Offer Insights on Healthcare Companies: Argenx Se (ARGX) and Avalo Therapeutics (AVTX) - The Globe and Mail
Argenx SE stock (NL0010832176): Is Vyvgart's U.S. expansion strong enough to unlock new upside? - AD HOC NEWS
Argenx shares see TD Cowen reiterate Buy on Vyvgart strength By Investing.com - Investing.com South Africa
Argenx shares see TD Cowen reiterate Buy on Vyvgart strength - Investing.com
Argenx SE stock (NL0010832176): Is Vyvgart's U.S. dominance now the key growth lever? - AD HOC NEWS
Argenx and Vertex Pharmaceuticals named BofA top biotech picks for 2026 By Investing.com - Investing.com South Africa
Argenx Leads Turnover Charts with $250 Million in Trades, Concealing a Slight Decline During Sector Shifts - Bitget
How is argenx (ARGX) Stock performing in 2026 | ARGX Q4 Earnings: Beats Estimates by $1.77Share Dilution - Newser
ARGX Technical Analysis | Trend, Signals & Chart Patterns | ARGENX SEADR (NASDAQ:ARGX) - ChartMill
Folia Health Launches App-Based Study to Unlock Novel Real-World Evidence of Symptom Burden and Unmet Need for Patients and Caregivers in CIDP - GlobeNewswire Inc.
Stocks Showing Improved Relative Strength: argenx ADR - Investor's Business Daily
Target Upgraded, Robinhood Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Argenx SE Stock: Biotech Leader in Autoimmune Therapies Driving Investor Interest with Strong Growth - AD HOC NEWS
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
ExxonMobil Upgraded, Microsoft Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Why Is Viridian Therapeutics Stock Falling Monday? - Sahm
argenx SE (HAM:1AEA) Stock Price, Trades & News - GuruFocus
$100 Invested In argenx 5 Years Ago Would Be Worth This Much Today - Sahm
Argenx SE Stock Faces Pressure Amid Pipeline Setbacks and Market Volatility in Biotech Sector - ad-hoc-news.de
Morgan Stanley Upgraded, Tyson Foods Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Form 6K argenx NV ADR For: 20 March By Investing.com - Investing.com South Africa
Form 6K argenx NV ADR For: 20 March - Investing.com
argenx announces Annual General Meeting of Shareholders on May 6, 2026 - ChartMill
Analysts Offer Insights on Healthcare Companies: BeOne Medicines (ONC), Argenx Se (ARGX) and Erasca (ERAS) - The Globe and Mail
Argenx SE stock faces pressure as Iron Triangle Partners trims position amid biotech sector watchlis - AD HOC NEWS
TD Cowen reiterates argenx stock Buy rating on growth outlook By Investing.com - Investing.com India
TD Cowen reiterates argenx stock Buy rating on growth outlook - Investing.com
Deutsche Bank lifts Argenx to Buy as valuation ’no longer demanding’ - Investing.com South Africa
0.29%
1.19%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):